FDA
-
-
-
-
-
-
-
Fluidigm (FLDM) Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution
-
-
-
-
-
-
-
Fluidigm (FLDM) Files Prelim Proxy Statement for Proposed $250M Investment from Casdin Capital and Viking Global Investors
-
-
-
-
-
-
-
Fluidigm (FLDM) Announces FDA Grants EUA for Home Collection Kit for Advanta Dx SARS-CoV-2 RT-PCR Assay
-
-
-
-
-
-
-
Fluidigm (FLDM) Announces Key Regulatory Body in India Grants Commercial License for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay
-
-
-
-
-
-
-
Dante Labs Launching COVID-19 Testing in Europe Utilizing Fluidigm Pathogen Detection Kit on Biomark HD Platform
-
-
-
-
-
-
-
Fluidigm (FLDM) Announces ImmunoGenomics and Vero Diagnostics Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform
-
-
-
-
-
-
-
Fluidigm (FLDM) Granted FDA EUA for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19
-
322,680 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

